about
Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociceptionResolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancerProstaglandin E Receptor Subtype 4 Signaling in the Heart: Role in Ischemia/Reperfusion Injury and Cardiac HypertrophyHealth effects of dietary phospholipidsMutations in the prostaglandin transporter encoding gene SLCO2A1 cause primary hypertrophic osteoarthropathy and isolated digital clubbingSecretory phospholipase A2 enzymes as pharmacological targets for treatment of diseaseDual functions of the trans-2-enoyl-CoA reductase TER in the sphingosine 1-phosphate metabolic pathway and in fatty acid elongation.Serum fatty acid profile does not reflect seafood intake in adolescents with atopic eczema.ABCG1 is required for pulmonary B-1 B cell and natural antibody homeostasis.A simple method to identify ether lipids in spermatozoa samples by MALDI-TOF mass spectrometry.β-glucans and eicosapolyenoic acids as MAMPs in plant-oomycete interactions: past and presentAnti-allergic effect of a Korean traditional medicine, Biyeom-Tang on mast cells and allergic rhinitis.Dietary supplementation with arachidonic acid increases arachidonic acid content in paw, but does not affect arthritis severity or prostaglandin E2 content in rat adjuvant-induced arthritis modelCytosolic phospholipase A2 modulates TLR2 signaling in synoviocytesAlteration in metabolic signature and lipid metabolism in patients with angina pectoris and myocardial infarction.Lipid Fingerprinting in Mild versus Severe Forms of Gestational Diabetes MellitusDrosophila spermatid individualization is sensitive to temperature and fatty acid metabolismBasic aspects of tumor cell fatty acid-regulated signaling and transcription factors.Zebrafish: a model for the study of addiction geneticsRole of omega-3 polyunsaturated fatty acids in the production of prostaglandin E2 and nitric oxide during experimental murine paracoccidioidomycosis.Dietary supplementation of arachidonic acid increases arachidonic acid and lipoxin A₄ contents in colon, but does not affect severity or prostaglandin E₂ content in murine colitis model.Use of a soluble epoxide hydrolase inhibitor as an adjunctive analgesic in a horse with laminitis.Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales.Biomarkers of fish oil omega-3 polyunsaturated fatty acids intake in humans.Activation of PPARδ: from computer modelling to biological effects.Targeted quantification of lipid mediators in skeletal muscles using restricted access media-based trap-and-elute liquid chromatography-mass spectrometry.Dose-dependent effects of prostaglandin E2 in macrophage adhesion and migration.Marine Lipids on Cardiovascular Diseases and Other Chronic Diseases Induced by Diet: An Insight Provided by Proteomics and Lipidomics.Challenges in Fatty Acid and lipid physiology.Effects of Marine Phospholipids Extract on the Lipid Levels of Metastatic and Nonmetastatic Prostate Cancer Patients.Prostaglandin E2 alteration in contraceptive consumers: as a risk factor for inflammatory diseases.Sweat lipid mediator profiling: a noninvasive approach for cutaneous research.Metabolomic analysis of rat plasma following chronic low-dose exposure to dichlorvos.Bioactive Lipids and Redox Signaling: Molecular Mechanism and Disease Pathogenesis.Host triacylglycerols shape the lipidome of intracellular trypanosomes and modulate their growth.Bioproduction of prostaglandins in a transgenic liverwort, Marchantia polymorpha.Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway
P2860
Q24628660-33BB00B6-39E9-408C-A8EC-06D660995AB7Q26741524-A78DB8BB-91FE-4268-92F5-C9DD2E47EF40Q26748618-981D25A9-37A1-49B5-BEFF-8F9E7F7111EBQ27025184-5E2E1E43-6455-4181-B084-679BC46B5F79Q28259682-163E531D-E461-4320-B00C-7A7DF49D4687Q33923169-7E8A53FB-31C2-4A48-9098-14202E56A967Q34138890-4F3D01BC-0685-4DD7-A681-EA58201EE7AEQ34477460-45086DEA-C2D2-4529-9C1E-B27777C76014Q34550498-B4668DC0-B9A5-4AA8-BEDA-1BEC7E236399Q34787218-CE53D394-9282-49E7-B92C-65080D32A519Q34932804-1769942B-3B53-411E-A3AD-D35816BE2FCFQ35093070-935374FB-88BF-4E47-A0EB-B2D327C9B13CQ35562274-1085CE50-038E-492C-93C1-5D8DA7CA51ADQ35609712-68EDE4BD-ADAB-4F78-961D-8DDFFC65CF03Q35741256-3F2CA187-6498-4BF0-AFD0-319056B4BB8BQ35860169-FCB90093-C9D6-426B-AA7C-3125D99941C1Q36088132-CDFE28FB-F88C-4BFC-83C3-79BB5C73B3CAQ36294936-42A7478A-5C55-43C2-ABE3-0519F5255FB2Q37387341-149A0C7D-9F46-4D37-97A8-1B4390FB9929Q37457086-CED58548-3E9C-466C-8A66-31D5DD6905F5Q37592744-9AABF673-33B3-4E66-BA60-FA5C4B62DE34Q37641590-92B0745F-3E6E-4880-AA72-9CC7D68F6935Q38130312-D1C0D6FA-459F-4915-9219-DA6BBDC45526Q38171245-1EA83F5C-2675-4C04-AEBB-4DCF1A2DF1EAQ38254275-E6D4DCC4-40F3-4C64-BC5E-AB12C4BCDD87Q38636997-5E4AEB35-A370-4222-BBFE-E103B99B8FDBQ40885179-A9BBB7CB-F7B5-4D81-AC44-EE8145E2539EQ41569982-D62BE14E-8F0C-4795-81F2-1B3C957757FCQ42003283-6A590E5B-56C1-4FE7-9C8A-75B8EF45ED38Q42096191-0D93A8AA-466B-4B68-B200-8898AC8319E6Q44456535-A0EDC222-50DF-4A3E-82BB-8A146766F9E0Q44594347-C693B0E2-02C4-4660-8727-FB4953ED5C2AQ45398946-CA61D99F-1681-4A4D-BCB1-F1AFB9EC1E3DQ46174417-E36BC9D2-2DAD-48F9-9FFD-AB220BDC6545Q47761949-67557CB2-AB58-40A3-8435-E0B74B4A30B0Q50494173-532292A9-B90C-438A-A08F-76BD95E2A517Q58558257-2C49BBBF-8F5A-4490-8636-2BD3E2564E36
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipid mediators in life science.
@en
Lipid mediators in life science.
@nl
type
label
Lipid mediators in life science.
@en
Lipid mediators in life science.
@nl
prefLabel
Lipid mediators in life science.
@en
Lipid mediators in life science.
@nl
P356
P1433
P1476
Lipid mediators in life science.
@en
P2093
Makoto Murakami
P356
10.1538/EXPANIM.60.7
P577
2011-01-01T00:00:00Z